Serum brain-derived tau distinguishes acute neurotrauma diagnoses
This study demonstrates that serum brain-derived tau (BD-tau) is a highly accurate, minimally invasive biomarker capable of rapidly distinguishing traumatic brain injury from spinal cord injury, outperforming both cerebrospinal fluid measurements and other established blood biomarkers to support early clinical decision-making and precision diagnostics in acute neurotrauma.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
When the body suffers a severe blow to the head or a crushing injury to the spine, the immediate medical challenge is often one of confusion. Both traumatic brain injury and spinal cord injury can leave a patient unconscious or unable to move, and their symptoms frequently overlap in the chaotic first hours after an accident. Doctors rely on scans and physical exams to tell them what has happened, but these tools are not always available or clear when a patient is too unstable to move. The result is a critical gap in care: without a quick way to distinguish between a brain injury and a spinal injury, it becomes difficult to choose the right treatment, predict the outcome, or enroll the patient in the correct clinical trials. For decades, scientists have searched for a biological signal in the blood that could act as a definitive flag, a molecule that rises only when the brain is hurt and stays low when the spine is the problem.
A team of researchers at the University of Pittsburgh has now identified such a signal. They focused on a specific type of protein called tau, which is found in the nervous system. While the body produces many versions of this protein, the researchers were interested in a particular form that originates almost exclusively in the brain. They developed a highly sensitive test to detect this "brain-derived tau" in a simple blood sample. The study involved hundreds of patients admitted to a trauma center, including those with severe brain injuries, those with spinal cord injuries, and healthy volunteers. The researchers measured the levels of this protein in the blood of these individuals shortly after their injuries and tracked how the levels changed over several days.
The findings were striking. In patients with brain injuries, the levels of this brain-specific protein in the blood were dramatically high. In contrast, patients with spinal cord injuries showed levels that were barely detectable, similar to those of the healthy volunteers. This clear separation allowed the test to distinguish between the two types of injuries with a high degree of accuracy. The researchers found that this blood test was even better at making the distinction than looking at the fluid that surrounds the brain and spinal cord, which is typically obtained through a more invasive procedure. Furthermore, the test outperformed other existing blood markers that are currently used to diagnose head injuries, which tend to rise in both brain and spinal injuries and therefore cannot tell them apart.
The study also revealed how the body responds to these injuries over time. In patients with brain injuries, the high levels of the protein remained elevated for up to six days, slowly declining but staying well above normal. In patients with spinal cord injuries, the levels remained low and flat throughout the same period. This difference in behavior provided another layer of certainty: the trajectory of the protein in the blood told a different story for each injury type. The researchers also observed that the amount of protein in the blood corresponded to the severity of the brain injury, with the most severe cases showing the highest levels.
This work suggests that a simple blood draw could soon become a powerful tool for doctors in emergency rooms. By measuring this specific protein, medical teams could rapidly confirm whether a patient's primary injury is in the brain or the spine, even before imaging scans are possible. This distinction is vital because the treatments and long-term care plans for these two conditions are fundamentally different. While the study was conducted in a single hospital with a specific group of patients, the results offer a promising path toward more precise and faster diagnosis for anyone suffering from acute neurotrauma. The ability to quickly and accurately identify the source of the injury could help guide immediate life-saving decisions and improve the chances of recovery for patients in the most critical moments after an accident.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.